Human pharmacokinetics of XBD173 and etifoxine distinguish their potential for pharmacodynamic effects mediated by translocator protein.
Journal Information
Full Title: Br J Clin Pharmacol
Abbreviation: Br J Clin Pharmacol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"COMPETING INTERESTS P.M.M. notes consultancy fees from Novartis and Biogen. He has received honoraria or speakers' honoraria from Novartis, Biogen and Roche and has received research or educational funds from Biogen, Novartis and GlaxoSmithKline."
Funding Disclosure
Evidence found in paper:
"Funding information MRC Clinician Scientist Fellowship, Grant/Award Number: MR/N008219/1; NIHR Biomedical Research Centre, Grant/Award Number: MR/N016343/1; UK Dementia Research Institute; National Institute for Health Research (NIHR) Senior Investigator Award; Lily Safra; Edmond J Safra Foundation"
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025